SEC Form 4 Latest Filings for ARCA biopharma, Inc. (Nasdaq: ABIO)

SEC Form 4 details and latest filings of insiders (officer, director, 10% stockholder, and anyone who possesses inside information) buying and selling ARCA biopharma, Inc. (ABIO) stocks, listed on Nasdaq, within the last 150 days.

There were no trades reported by the insiders.